82 related articles for article (PubMed ID: 9004089)
1. Genetic determinants and renal mechanisms in essential hypertension.
Manunta P; Del Vecchio L; Amar K; Bianchi G
J Hum Hypertens; 1996 Oct; 10(10):649-56. PubMed ID: 9004089
[TBL] [Abstract][Full Text] [Related]
2. Renal genetic mechanisms of essential hypertension.
Manunta P; Cerutti R; Bernardi L; Stella P; Bianchi G
J Nephrol; 1997; 10(4):172-8. PubMed ID: 9377722
[TBL] [Abstract][Full Text] [Related]
3. Renal mechanisms of genetic hypertension: from the molecular level to the intact organism.
Cusi D; Bianchi G
Kidney Int; 1996 Jun; 49(6):1754-9. PubMed ID: 8743491
[TBL] [Abstract][Full Text] [Related]
4. Genetic aspects of ion transport systems in hypertension.
Bianchi G; Ferrari P; Cusi D; Tripodi G; Barber B
J Hypertens Suppl; 1990 Dec; 8(7):S213-8. PubMed ID: 1710265
[TBL] [Abstract][Full Text] [Related]
5. A renal abnormality in the Milan hypertensive strain of rats and in humans predisposed to essential hypertension.
Bianchi G; Ferrari P; Salvati P; Salardi S; Parenti P; Cusi D; Guidi E
J Hypertens Suppl; 1986 Oct; 4(3):S33-6. PubMed ID: 3537235
[TBL] [Abstract][Full Text] [Related]
6. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport.
Tripodi G; Valtorta F; Torielli L; Chieregatti E; Salardi S; Trusolino L; Menegon A; Ferrari P; Marchisio PC; Bianchi G
J Clin Invest; 1996 Jun; 97(12):2815-22. PubMed ID: 8675693
[TBL] [Abstract][Full Text] [Related]
7. Cell membrane abnormalities and genetic hypertension.
Bianchi G; Ferrari P; Cusi D; Guidi E; Salardi S; Torielli L; Tripodi MG; Niutta E; Elli A; Vezzoli G
J Clin Hypertens; 1986 Jun; 2(2):114-9. PubMed ID: 3531412
[TBL] [Abstract][Full Text] [Related]
8. Genetics of renal mechanisms of primary hypertension: the role of adducin.
Barlassina C; Citterio L; Bernardi L; Buzzi L; D'Amico M; Sciarrone T; Bianchi G
J Hypertens; 1997 Dec; 15(12 Pt 2):1567-71. PubMed ID: 9488207
[TBL] [Abstract][Full Text] [Related]
9. Adducin in essential hypertension.
Manunta P; Barlassina C; Bianchi G
FEBS Lett; 1998 Jun; 430(1-2):41-4. PubMed ID: 9678591
[TBL] [Abstract][Full Text] [Related]
10. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.
Manunta P; Bianchi G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S30-5. PubMed ID: 16565244
[TBL] [Abstract][Full Text] [Related]
12. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
13. A genetic approach to the pathogenesis of primary hypertension and to its treatment.
Bianchi G; Ferrari P
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):S399-405. PubMed ID: 8846504
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of gamma-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55.
Tripodi G; Szpirer C; Reina C; Szpirer J; Bianchi G
Biochem Biophys Res Commun; 1997 Aug; 237(3):685-9. PubMed ID: 9299427
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific effects of dual ET-1/ANG II receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model.
Kaneko Y; Herrera VL; Didishvili T; Ruiz-Opazo N
Physiol Genomics; 2005 Jan; 20(2):157-64. PubMed ID: 15561758
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific QTLs and interacting loci underlie salt-sensitive hypertension and target organ complications in Dahl S/jrHS hypertensive rats.
Herrera VL; Tsikoudakis A; Ponce LR; Matsubara Y; Ruiz-Opazo N
Physiol Genomics; 2006 Aug; 26(3):172-9. PubMed ID: 16720678
[TBL] [Abstract][Full Text] [Related]
17. Renal abnormalities at the prehypertensive stage of essential hypertension.
Bianchi G; Cusi D; Ferrari P; Barlassina C; Pati P; Salardi S; Torielli L; Ferrandi M; Salvati P; Vezzoli G
J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S43-8. PubMed ID: 2467105
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
Majid DS; Kopkan L
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
[TBL] [Abstract][Full Text] [Related]
19. Molecular variants of the thiazide-sensitive Na+-Cl- cotransporter in hypertensive families.
Keszei AP; Tislér A; Backx PH; Andrulis IL; Bull SB; Logan AG
J Hypertens; 2007 Oct; 25(10):2074-81. PubMed ID: 17885550
[TBL] [Abstract][Full Text] [Related]
20. Regulation of renal calbindin-D28K.
Hemmingsen C
Pharmacol Toxicol; 2000; 87 Suppl 3():5-30. PubMed ID: 11097107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
